Michael Andrew Chambers - Director at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Andrew Chambers since 09 Mar 2025

Holdings reported by Michael Andrew Chambers for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 284,034 $28,440,324 $100.13 10 Mar 2025 By Revocable Trust
Common Stock 10,660 $1,067,386 $100.13 10 Mar 2025 Direct
Stock Options (right to buy) 4,792 10 Mar 2025 Direct Common Stock
Convertible Senior Notes $20,000,000 18 Dec 2025 By Revocable Trust Common Stock

Transactions reported by Michael Andrew Chambers for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.